An update from VolitionRX (VNRX) is now available.
At the recent Annual Meeting, stockholders of the Company made key decisions affecting the future of the firm. Six Board of Directors members were elected, an independent accounting firm was ratified for the upcoming year, and executive compensation was approved via a non-binding advisory vote. Additionally, an amendment to the Restated Certificate passed, and the 2024 Stock Incentive Plan was approved, marking significant steps in the Company’s governance and strategic incentive alignment.
For detailed information about VNRX stock, go to TipRanks’ Stock Analysis page.
